Stockreport

Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights

Clene Inc.  (CLNN) 
PDF Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the conf [Read more]